Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Placebo-controlled Clinical Trial of Tanshinone Capsules in the Treatment of Patients With COVID-19

NCT07123701 is registered in ClinicalTrials.gov with Liu Shuwen as lead sponsor.

NCT NCT07123701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07123701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Placebo-controlled Clinical Trial of Tanshinone Capsules in the Treatment of Patients With COVID-19
Lead sponsor
Liu Shuwen
Phase
Phase 2/3
Overall status
Completed
Start date
March 1, 2024
Completion date
July 1, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 (coronavirus disease 2019)